{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:58:40Z","timestamp":1775293120224,"version":"3.50.1"},"reference-count":20,"publisher":"BMJ","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Genet"],"published-print":{"date-parts":[[1993,12]]},"abstract":"<jats:p>An analysis of social and ethical aspects of presymptomatic testing for Huntington's disease has been carried out, based on data on linked DNA markers, from four major testing centres in different European Community countries (Belgium, Italy, Netherlands, and United Kingdom). Information was available on 603 applicants, with 213 final results given, of which 32% gave an increased risk. A series of specific issues and problems were documented systematically for all applicants, results being given on frequency of occurrence and illustrated by individual case histories. The principal issues could be grouped as problems of inappropriate referral, problems involving relatives, and problems relating to disclosure of results. At least one important problem was encountered in 46% of applicants, emphasising the importance of expert counselling, preparation, and support of applicants, and of close liaison between clinical, counselling, and laboratory staff. The extensive and detailed information available for Huntington's disease from this and other studies will be of considerable value in relation to genetic testing for other late onset genetic disorders and will be even more relevant to Huntington's disease now that specific mutation analysis is possible for this disorder.<\/jats:p>","DOI":"10.1136\/jmg.30.12.1028","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T15:23:16Z","timestamp":1226330596000},"page":"1028-1035","source":"Crossref","is-referenced-by-count":23,"title":["Ethical and social issues in presymptomatic testing for Huntington's disease: a European Community collaborative study. European Community Huntington's Disease Collaborative Study Group."],"prefix":"10.1136","volume":"30","member":"239","published-online":{"date-parts":[[1993,12,1]]},"reference":[{"key":"ref_1","article-title":"Huntington's disease","author":"Harper, P.S.","year":"1991","unstructured":"Harper PS. Huntington's disease. London: Saunders, 1991."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","unstructured":"The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington's disease","volume":"4","author":"Duyao, M.; Ambrose, C.; Myers, R.","year":"1993","unstructured":"Duyao M, Ambrose C, Myers R, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet 1993;4:387-92.","journal-title":"Nature Genet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng0893-393","article-title":"Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease","volume":"4","author":"Snell, R.G.; MacMillan, J.C.; Cheadle, J.P.","year":"1993","unstructured":"Snell RG, MacMillan JC, Cheadle JP, et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature Genet 1993;4:393-7.","journal-title":"Nature Genet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease","volume":"4","author":"Andrew, S.E.; Goldberg, Y.P.; Kremer, B.","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet 1993;4:398-403.","journal-title":"Nature Genet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/bmj.307.6901.396","article-title":"The gene for Huntington's disease","volume":"307","author":"Harding, A.E.","year":"1993","unstructured":"Harding AE. The gene for Huntington's disease. BMJ 1993;307:396-7.","journal-title":"BMJ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bmj.307.6901.397","article-title":"Clinical consequences of isolating the gene for Huntington's disease","volume":"307","author":"Harper, P.S.","year":"1993","unstructured":"Harper PS. Clinical consequences of isolating the gene for Huntington's disease. BMJ 1993;307:397-8.","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJM198803033180903","article-title":"Predictive testing for Huntington's disease with use of a linked DNA marker","volume":"318","author":"Meissen, G.J.; Myers, R.H.; Mastromauro, C.A.","year":"1988","unstructured":"Meissen GJ, Myers RH, Mastromauro CA, et al. Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl Med 1988;318:535-42.","journal-title":"N Engl Med"},{"key":"ref_9","first-page":"689","article-title":"Improved predictive testing for Huntington disease by using three linked DNA markers","volume":"43","author":"Hayden, M.R.; Robbins, C.; Allard, D.","year":"1988","unstructured":"Hayden MR, Robbins C, Allard D, et al. Improved predictive testing for Huntington disease by using three linked DNA markers. Am J Hum Genet 1988;43:689-94.","journal-title":"Am J Hum Genet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.1989.03420210056016","article-title":"Presymptomatic diagnosis of delayed-onset disease with linked DNA markers: the experience in Huntington's disease","volume":"261","author":"Brandt, J.; Quaid, K.; Folstein, S.E.","year":"1989","unstructured":"Brandt J, Quaid K, Folstein SE, et al. Presymptomatic diagnosis of delayed-onset disease with linked DNA markers: the experience in Huntington's disease. JAMA 1989;261:3108-14.","journal-title":"JAMA"},{"key":"ref_11","first-page":"603","article-title":"Uptake of presymptomatic predictive testing for Huntington's disease","volume":"ii:","author":"Craufurd, D.; Dodge, A.; Kerzin-Storrar, L.","year":"1989","unstructured":"Craufurd D, Dodge A, Kerzin-Storrar L, et al. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 1989;ii:603-5.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(89)92084-9","article-title":"Predictive testing for Huntington's disease with linked DNA markers","volume":"ii:","author":"Brock, D.H.; Mennie, M.; Curtis, A.","year":"1989","unstructured":"Brock DH, Mennie M, Curtis A, et al. Predictive testing for Huntington's disease with linked DNA markers. Lancet 1989;ii:463-6.","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.161.4.481","article-title":"Presymptomatic testing for Huntington's disease in Wales 1987-90","volume":"161","author":"Tyler, A.; Morris, M.; Lazarou, L.; Meredith, L.; Myring, J.; Harper, P.","year":"1992","unstructured":"Tyler A, Morris M, Lazarou L, Meredith L, Myring J, Harper P. Presymptomatic testing for Huntington's disease in Wales 1987-90. Br Psychiatry 1992;161:481-8. _","journal-title":"Br Psychiatry"},{"issue":"1","key":"ref_14","first-page":"127","article-title":"Presymptomatic DNA testing for Huntington disease in the Netherlands","volume":"28","author":"Tibben, A.; Vegter-vd Vlis, M.; Skraastad, M.I.","year":"1992","unstructured":"Tibben A, Vegter-vd Vlis M, Skraastad MI, et al. Presymptomatic DNA testing for Huntington disease in the Netherlands. Birth Defects 1992;28(1):127-31.","journal-title":"Birth Defects"},{"key":"ref_15","first-page":"601","article-title":"Problems in genetic prediction for Huntington's disease","volume":"ii:","author":"Morris, M.; Tyler, A.; Lazarou, L.; Meredith, L.; Harper, P.S.","year":"1989","unstructured":"Morris M, Tyler A, Lazarou L, Meredith L, Harper PS. Problems in genetic prediction for Huntington's disease. Lancet 1989;ii:601-3.","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jmg.27.1.34","article-title":"World Federation of Neurology Research Group on Huntington's Disease. Ethical issues policy statement on Huntington's disease molecular genetics predictive test","volume":"27","year":"1990","unstructured":"World Federation of Neurology Research Group on Huntington's Disease. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. J Med Genet 1990;27:34-8.","journal-title":"J Med Genet"},{"key":"ref_17","first-page":"1","article-title":"Predictive testing for Huntington's disease in childhood: challenges and implications","volume":"46","author":"Bloch, M.; Hayden, M.R.","year":"1990","unstructured":"Bloch M, Hayden MR. Predictive testing for Huntington's disease in childhood: challenges and implications. Am _ Hum Genet 1990;46:1-4.","journal-title":"Am _ Hum Genet"},{"issue":"1","key":"ref_18","first-page":"105","article-title":"Pitfalls in counseling for predictive testing in Huntington disease","volume":"28","author":"Demyttenaere, K.; Evers-Kiebooms, G.; Decruyenaere, M.","year":"1992","unstructured":"Demyttenaere K, Evers-Kiebooms G, Decruyenaere M. Pitfalls in counseling for predictive testing in Huntington disease. Birth Defects 1992;28(1):105-1 1.","journal-title":"Birth Defects"},{"issue":"1","key":"ref_19","first-page":"113","article-title":"Attitudes of persons at risk and their partners towards predictive testing","volume":"28","author":"Jacopini, G.A.; D'Amica, R.; Frontali, M.; Vivona, G.","year":"1992","unstructured":"Jacopini GA, D'Amica R, Frontali M, Vivona G. Attitudes of persons at risk and their partners towards predictive testing. Birth Defects 1992;28(1):113-17.","journal-title":"Birth Defects"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0140-6736(93)90080-Z","article-title":"Insurance and genetic testing","volume":"341","author":"Harper, P.S.","year":"1993","unstructured":"Harper PS. Insurance and genetic testing. Lancet 1993;341:224-7.","journal-title":"Lancet"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg.30.12.1028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:53:16Z","timestamp":1760734396000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg.30.12.1028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,12]]},"references-count":20,"journal-issue":{"issue":"12","published-online":{"date-parts":[[1993,12,1]]},"published-print":{"date-parts":[[1993,12]]}},"alternative-id":["10.1136\/jmg.30.12.1028"],"URL":"https:\/\/doi.org\/10.1136\/jmg.30.12.1028","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,12]]}}}